COMMUNIQUÉS West-GlobeNewswire

XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks
27/08/2018
Findings Demonstrate Ability of MABp1 (Bermekimab) to Block In Vitro Neutrophil Mediated Vascular Endothelial Activation and Thrombosis AUSTIN, Texas, Aug. 27, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) [...]
Brainsway Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update
27/08/2018
Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter 2017 Recently announced FDA clearance of Deep TMS system for treatment of OCD expected to drive further revenue [...]
Bio-Path Holdings Announces First Patient Dosed in Expansion of Phase 2 Trial of Prexigebersen in Acute Myeloid Leukemia
27/08/2018
Based on Encouraging Data, New Cohort Will Treat Patients in Combination with Decitabine HOUSTON, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its [...]
VIVUS Reports Data Supporting the Cardiovascular Safety of Qsymia®
27/08/2018
-Retrospective analysis presented at the 34 th International Conference on Pharmacoepidemiology & Therapeutic Risk Management- CAMPBELL, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “ [...]
ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
27/08/2018
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 27, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures and [...]
Transactions under Novozymes’ stock buyback program
27/08/2018
Please read the full announcement in the attached PDF Attachment 2018_51_Stock_Buybackprogram_EN
Arcturus Therapeutics to Present at Three Investor Conferences in September
27/08/2018
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that Joseph E. Payne will present at the upcoming conferences, including the B. [...]
Emerald Health Therapeutics Signs Term Sheet to Access Large-Scale Extraction, Softgel Production, and New Product Development Capabilities Through Strategic Alliance with Factors Group of Nutritional Companies
27/08/2018
Collaboration with natural health products leader positions Emerald with industry-leading manufacturing for value-added cannabis products, a significant growth opportunity in the legal medical and adult-use cannabis [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Six Months Ended June 30, 2018
27/08/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]
Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conferences
27/08/2018
WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Amendment: Biohit Oyj Managers' Transactions
27/08/2018
BIOHIT OYJ AMENDMENT: MANAGERS’ TRANSACTIONS 27 AUGUST 2018 At 13.00 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior [...]
JAY MOHR to Headline Fullerton Cares ‘Comedy Show for Autism’ - October 19
27/08/2018
FULLERTON, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- With new headliner JAY MOHR, the Fullerton Cares ‘Comedy Show for Autism’ in support of Fullerton autism charities and special education programs will be at the [...]
Wright Medical Group N.V. Enters Into Definitive Agreement to Acquire Cartiva, Inc.
27/08/2018
Will Add Unique PMA-Approved Technology for High Volume Foot & Ankle Procedure and Further Accelerate Growth Opportunities in Wright’s Extremities Business Purchase Price of $435 Million Cash Acquisition Expected to [...]
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
27/08/2018
Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple [...]
Loxo Oncology Announces Submission of European Marketing Authorization Application for Larotrectinib
27/08/2018
STAMFORD, Conn., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
Photocure ASA: Exclusive Nordic distribution agreement for innovative drug delivery system for bladder cancer patients
27/08/2018
Oslo, Norway, August 27, 2018 : Photocure ASA, The Bladder Cancer Company, announces today that an exclusive distribution agreement for the Nordic area for an innovative and patented medical device has been signed with [...]
FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials
27/08/2018
FIT Biotech Oy Press release 27.8.2018 at 08.30 AM EET FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials FIT Biotech Ltd ("FIT Biotech", FITBIO: FN Finland) has delivered the first [...]
Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)
27/08/2018
The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell [...]
BeiGene Announces Acceptance of its First New Drug Application for Zanubrutinib in Relapsed/Refractory Mantle Cell Lymphoma by China Drug Administration
27/08/2018
BEIJING, China and CAMBRIDGE, Mass., Aug. 26, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pages